{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:16:47Z","timestamp":1793049407862,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010248","name":"Zhejiang Province Public Welfare Technology Application Research Project","doi-asserted-by":"crossref","award":["LGC21H090001"],"award-info":[{"award-number":["LGC21H090001"]}],"id":[{"id":"10.13039\/501100010248","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801490"],"award-info":[{"award-number":["81801490"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81741076"],"award-info":[{"award-number":["81741076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Spinal muscular atrophy (SMA) is an autosomal-recessive motor neuron disease leading to dysfunction of multiple organs. SMA can impair the quality of life (QoL) of patients and family. We aimed to evaluate the QoL of children with SMA and their caregivers and to identify the factors associated with QoL in a cross-sectional study conducted in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We recruited 101 children aged 0\u201317\u00a0years with SMA and their caregivers from a children\u2019s hospital in China. Twenty-six children had type I SMA, 56 type II and 19 type III. Each child\u2019s QoL was measured by the Pediatric Quality of Life Inventory 3.0 Neuromuscular Module (PedsQL NMM), which was completed by the child\u2019s caregivers. The caregiver\u2019s QoL was measured by the Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM). Information on sociodemographic characteristics, disease-specific characteristics, and treatments were collected using the proxy-reported questionnaire. Two-sample\n                      <jats:italic>t<\/jats:italic>\n                      tests and one-way ANOVA were used to compare differences in average scores of QoL across subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Children with type III SMA had a higher average Total score of PedsQL NMM and higher average scores in domains Neuromuscular disease and Family resources than children with type I or type II SMA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Caregivers of children with type III SMA reported higher average scores in the domains of Physical, Emotional, Social, and Cognitive functioning of the PedsQL FIM than those of children with types I or II SMA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In addition, disease-related characteristics (e.g. limited mobility, stable course of disease, skeleton deformity, and digestive system dysfunction) and respiratory support were associated with lower average scores of PedsQL NMM and PedsQL FIM (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Exercise training, multidisciplinary team management and use of the medication Nusinersen were each associated with higher average scores in both PedsQL NMM and FIM (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study has demonstrated factors that may impair or improve QoL of children patients with SMA and their parents. Particularly, QoL was relatively poor in children with type I and type II SMA as well as in their caregivers compared to those with type III SMA. We strongly recommend that standard of care in a multidisciplinary team be strengthened to improve the QoL of SMA patients. Our study called for increased attention from clinical physicians on measuring QoL in their clinical practices in order to enhance the understanding of impacts of SMA and to make better decisions regarding treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-01638-8","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T13:03:54Z","timestamp":1609938234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Quality of life of children with spinal muscular atrophy and their caregivers from the perspective of caregivers: a Chinese cross-sectional study"],"prefix":"10.1186","volume":"16","author":[{"given":"Mei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6736-1407","authenticated-orcid":false,"given":"Shanshan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"1638_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.24864","volume":"81","author":"MA Farrar","year":"2017","unstructured":"Farrar MA, Park SB, Vucic S, Carey KA, Turner BJ, Gillingwater TH, et al. Emerging therapies and challenges in spinal muscular atrophy. Ann Neurol. 2017;81:355\u201368.","journal-title":"Ann Neurol"},{"key":"1638_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrneurol.2018.4","volume":"14","author":"EJN Groen","year":"2018","unstructured":"Groen EJN, Talbot K, Gillingwater TH. Advances in therapy for spinal muscular atrophy: promises and challenges. Nat Rev Neurol. 2018;14:214\u201324.","journal-title":"Nat Rev Neurol"},{"key":"1638_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1750-3639.2001.tb00395.x","volume":"11","author":"H Schmalbruch","year":"2001","unstructured":"Schmalbruch H, Haase G. Spinal muscular atrophy: present state. Brain Pathol. 2001;11:231\u201347.","journal-title":"Brain Pathol"},{"key":"1638_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4137\/JEN.S33122","volume":"10","author":"S Ahmad","year":"2016","unstructured":"Ahmad S, Bhatia K, Kannan A, Gangwan L. Molecular mechanisms of neurodegeneration in spinal muscular atrophy. J Exp Neurosci. 2016;10:39\u201349.","journal-title":"J Exp Neurosci"},{"key":"1638_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.nurt.2008.08.007","volume":"5","author":"M Oskoui","year":"2008","unstructured":"Oskoui M, Kaufmann P. Spinal muscular atrophy. Neurotherapeutics. 2008;5:499\u2013506.","journal-title":"Neurotherapeutics"},{"key":"1638_CR6","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0883073807305673","volume":"22","author":"BS Russman","year":"2016","unstructured":"Russman BS. Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurol. 2016;22:946\u201351.","journal-title":"J Child Neurol"},{"key":"1638_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","volume":"11","author":"E Mercuri","year":"2012","unstructured":"Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012;11:443\u201352.","journal-title":"Lancet Neurol"},{"key":"1638_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrneurol.2015.77","volume":"11","author":"I Faravelli","year":"2015","unstructured":"Faravelli I, Nizzardo M, Comi GP, Corti S. Spinal muscular atrophy\u2013recent therapeutic advances for an old challenge. Nat Rev Neurol. 2015;11:351\u20139.","journal-title":"Nat Rev Neurol"},{"key":"1638_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/JND-190399","volume":"7","author":"CJ Cynthia","year":"2020","unstructured":"Cynthia CJ, Suzanne FC, Jill J, Lisa B, Sandra PR, John S, et al. Spinal muscular atrophy (SMA) subtype concordance in siblings: findings from the cure SMA cohort. J Neuromuscul Dis. 2020;7:33\u201340.","journal-title":"J Neuromuscul Dis"},{"key":"1638_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/joa.12083","volume":"224","author":"M Shababi","year":"2014","unstructured":"Shababi M, Lorson CL, Rudnik Sch\u00f6neborn SS. Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease? J Anat. 2014;224:15\u201328.","journal-title":"J Anat"},{"key":"1638_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","volume":"19","author":"G Hamilton","year":"2013","unstructured":"Hamilton G, Gillingwater TH. Spinal muscular atrophy: going beyond the motor neuron. Trends Mol Med. 2013;19:40\u201350.","journal-title":"Trends Mol Med"},{"key":"1638_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2174\/1566524016666161128113338","volume":"16","author":"LA Nash","year":"2016","unstructured":"Nash LA, Burns JK, Chardon JW, Kothary R, Parks RJ. Spinal muscular atrophy: more than a disease of motor neurons? Curr Mol Med. 2016;16:779\u201392.","journal-title":"Curr Mol Med"},{"key":"1638_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: Part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28:197\u2013207.","journal-title":"Neuromuscul Disord"},{"key":"1638_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28:103\u201315.","journal-title":"Neuromuscul Disord"},{"key":"1638_CR15","first-page":"18","volume":"28","author":"R Grychtol","year":"2018","unstructured":"Grychtol R, Abel F, Fitzgerald DA. The role of sleep diagnostics and non-invasive ventilation in children with spinal muscular atrophy. Paediatr Respir Rev. 2018;28:18\u201325.","journal-title":"Paediatr Respir Rev"},{"key":"1638_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.22603\/ssrr.2017-0093","volume":"2","author":"S Takei","year":"2018","unstructured":"Takei S, Miyagi M, Saito W, Imura T, Inoue G, Nakazawa T, et al. Safety and efficacy of treatment for scolios is secondary to spinal muscular atrophy fused to lumbar 5 level. Spine Surg Relat Res. 2018;2:294\u20138.","journal-title":"Spine Surg Relat Res"},{"key":"1638_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pediatrneurol.2015.12.015","volume":"57","author":"NM Mehta","year":"2016","unstructured":"Mehta NM, Newman H, Tarrant S, Graham RJ. Nutritional status and nutrient intake challenges in children with spinal muscular atrophy. Pediatr Neurol. 2016;57:80\u20133.","journal-title":"Pediatr Neurol"},{"key":"1638_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/mds.26885","volume":"32","author":"MP Martinez","year":"2017","unstructured":"Martinez MP. What is quality of life and how do we measure it? Relevance to Parkinson\u2019s disease and movement disorders. Mov Disord. 2017;32:382\u201392.","journal-title":"Mov Disord"},{"key":"1638_CR19","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1007\/s11136-017-1651-0","volume":"26","author":"P Vanleerberghe","year":"2017","unstructured":"Vanleerberghe P, De Witte N, Claes C, Schalock RL, Vert\u00e9 D. The quality of life of older people aging in place: a literature review. Qual Life Res. 2017;26:2899\u2013907.","journal-title":"Qual Life Res"},{"key":"1638_CR20","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s11136-019-02214-9","volume":"28","author":"K Haraldstad","year":"2019","unstructured":"Haraldstad K, Wahl A, Andenaes R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 2019;28:2641\u201350.","journal-title":"Qual Life Res"},{"key":"1638_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.nmd.2017.01.018","volume":"27","author":"F Rouault","year":"2017","unstructured":"Rouault F, Christie-Brown V, Broekgaarden R, Gusset N, Henderson D, Marczuk P, et al. Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients. Neuromuscul Disord. 2017;27:428\u201338.","journal-title":"Neuromuscul Disord"},{"key":"1638_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0883073819900463","volume":"35","author":"MS Weaver","year":"2020","unstructured":"Weaver MS, Hanna R, Hetzel S, Patterson K, Yuroff A, Sund S, et al. A prospective, crossover survey study of child- and proxy-reported quality of life according to spinal muscular atrophy type and medical interventions. J Child Neurol. 2020;35:322\u201330.","journal-title":"J Child Neurol"},{"key":"1638_CR23","first-page":"806","volume":"37","author":"J Hu","year":"2012","unstructured":"Hu J, Jiang L, Hong SQ, Cheng L, Kong M, Ye YZ. Reliability and validity for Chinese version of pediatric quality of life inventory TM(PedsQLTM) 30 neuromuscular module. J Chongqing Med Univ. 2012;37:806\u201310.","journal-title":"J Chongqing Med Univ"},{"key":"1638_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-7525-9-16","volume":"9","author":"RQ Chen","year":"2011","unstructured":"Chen RQ, Hao YT, Feng LF, Zhang YF, Huang ZY. The Chinese version of the Pediatric Quality of Life InventoryTM (PedsQLTM) Family Impact Module: cross-cultural adaptation and psychometric evaluation. Health Quality Life Outcomes. 2011;9:16.","journal-title":"Health Quality Life Outcomes"},{"key":"1638_CR25","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: L. Erlbaum; 1988.","edition":"2"},{"key":"1638_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1186\/s12889-018-6082-5","volume":"18","author":"R Min","year":"2018","unstructured":"Min R, Linli P, Qin L, Michelle P, Fang H, Hong W. The association between quality of life (QoL) and health literacy among junior middle school students: a cross-sectional study. BMC Public Health. 2018;18:1183.","journal-title":"BMC Public Health"},{"key":"1638_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bone.2015.05.039","volume":"79","author":"S Vai","year":"2015","unstructured":"Vai S, Bianchi ML, Moroni I, Mastella C, Broggi F, Morandi L, et al. Bone and spinal muscular atrophy. Bone. 2015;79:116\u201320.","journal-title":"Bone"},{"key":"1638_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1469-8749.1989.tb04029.x","volume":"31","author":"L Merlini","year":"1989","unstructured":"Merlini L, Granata C, Bonfiglioli S, Marini ML, Cervellati S, Savini R. Scoliosis in spinal muscular atrophy: natural history and management. Dev Med Child Neurol. 1989;31:501\u20138.","journal-title":"Dev Med Child Neurol"},{"key":"1638_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nmd.2019.02.011","volume":"29","author":"CH Cremers","year":"2019","unstructured":"Cremers CH, Fischer MJ, Kruitwagen-van Reenen ET, Wadman RI, Vervoordeldonk JJ, Verhoef M. Participation and mental well-being of mothers of home-living patients with spinal muscular atrophy. Neuromuscul Disord. 2019;29:321\u20139.","journal-title":"Neuromuscul Disord"},{"key":"1638_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11914-017-0396-6","volume":"15","author":"L Veilleux","year":"2017","unstructured":"Veilleux L, Rauch F. Muscle-bone interactions in pediatric bone diseases. Curr Osteoporos Rep. 2017;15:425\u201332.","journal-title":"Curr Osteoporos Rep"},{"key":"1638_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2165\/00007256-200737090-00001","volume":"37","author":"VG Coffey","year":"2007","unstructured":"Coffey VG, Hawley JA. The molecular bases of training adaptation. Sports Med. 2007;37:737\u201363.","journal-title":"Sports Med"},{"key":"1638_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-015-0585-6","volume":"15","author":"RW Motl","year":"2015","unstructured":"Motl RW, Sandroff BM. Benefits of exercise training in multiple sclerosis. Curr Neurol Neurosci Rep. 2015;15:1\u20139.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1638_CR33","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1139\/apnm-2018-0229","volume":"43","author":"S Ng","year":"2018","unstructured":"Ng S, Manta A, Ljubicic V. Exercise biology of neuromuscular disorders. Appl Physiol Nutr Metab. 2018;43:1194\u2013206.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"Suppl 2","key":"1638_CR34","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1542\/peds.2018-0333D","volume":"142","author":"LE Case","year":"2018","unstructured":"Case LE, Apkon SD, Eagle M, Gulyas A, Juel L, Matthews D, et al. Exercise management of the patient with duchenne muscular dystrophy. Pediatrics (Evanston). 2018;142(Suppl 2):S17-33.","journal-title":"Pediatrics (Evanston)"},{"key":"1638_CR35","first-page":"CD003907","volume":"12","author":"NB Voet","year":"2019","unstructured":"Voet NB, van der Kooi EL, van Engelen BG, Geurts AC. Strength training and aerobic exercise training for muscle disease. Rev Cochrane Database Syst Rev. 2019;12:CD003907.","journal-title":"Rev Cochrane Database Syst Rev"},{"key":"1638_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.spen.2016.12.003","volume":"24","author":"P Mehta","year":"2017","unstructured":"Mehta P, Melikishvili A, Carvalho KS. Neurological complications of respiratory disease. Semin Pediatr Neurol. 2017;24:14\u201324.","journal-title":"Semin Pediatr Neurol"},{"key":"1638_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/WCO.0000000000000470","volume":"30","author":"M Boentert","year":"2017","unstructured":"Boentert M, Wenninger S, Sansone VA. Respiratory involvement in neuromuscular disorders. Curr Opin Neurol. 2017;30:529\u201337.","journal-title":"Curr Opin Neurol"},{"key":"1638_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/JMDH.S93680","volume":"9","author":"Y Von Kodolitsch","year":"2016","unstructured":"Von Kodolitsch Y, Rybczynski M, Vogler M, Mir T, Sch\u00fcler H, Kutsche K, et al. The role of the multidisciplinary health care team in the management of patients with Marfan syndrome. J Multidiscip Healthc. 2016;9:587\u2013614.","journal-title":"J Multidiscip Healthc"},{"key":"1638_CR39","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1111\/hsc.12536","volume":"26","author":"J Brook","year":"2018","unstructured":"Brook J, McGraw C. Multidisciplinary perspectives: application of the consolidated framework for implementation research to evaluate a health coaching initiative. Health Soc Care Community. 2018;26:e386\u201395.","journal-title":"Health Soc Care Community"},{"key":"1638_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13023-019-1072-y","volume":"14","author":"S Auvin","year":"2019","unstructured":"Auvin S, Bissler JJ, Cottin V, Fujimoto A, Hofbauer G, Jansen AC, et al. A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report. Orphanet J Rare Dis. 2019;14:91.","journal-title":"Orphanet J Rare Dis"},{"key":"1638_CR41","doi-asserted-by":"publisher","first-page":"e514","DOI":"10.1002\/mgg3.514","volume":"7","author":"J Duis","year":"2019","unstructured":"Duis J, van Wattum PJ, Scheimann A, Salehi P, Brokamp E, Fairbrother L, et al. A multidisciplinary approach to the clinical management of Prader-Willi syndrome. Mol Genet Genomic Med. 2019;7:e514.","journal-title":"Mol Genet Genomic Med"},{"key":"1638_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pan.2018.04.013","volume":"18","author":"M Abu-El-Haija","year":"2018","unstructured":"Abu-El-Haija M, Nathan JD. Pediatric chronic pancreatitis: updates in the 21st century. Pancreatology. 2018;18:354\u20139.","journal-title":"Pancreatology"},{"key":"1638_CR43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/ajhp\/58.15.1413","volume":"58","author":"DS Chan","year":"2001","unstructured":"Chan DS, Callahan CW, Moreno C. Multidisciplinary education and management program for children with asthma. Am J Health Syst Pharm. 2001;58:1413\u20137.","journal-title":"Am J Health Syst Pharm"},{"key":"1638_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nn.4508","volume":"20","author":"DR Corey","year":"2017","unstructured":"Corey DR. Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. Nat Neurosci. 2017;20:497\u20139.","journal-title":"Nat Neurosci"},{"key":"1638_CR45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1212\/WNL.0000000000006502","volume":"20","author":"D Michelson","year":"2018","unstructured":"Michelson D, Ciafaloni E, Ashwal S, Lewis E, Narayanaswami P, Oskoui M, et al. Evidence in focus: Nusinersen use in spinal muscular atrophy. Neurology. 2018;20:923\u201333.","journal-title":"Neurology"},{"key":"1638_CR46","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40263-019-00656-w","volume":"33","author":"BT Darras","year":"2019","unstructured":"Darras BT, Farrar MA, Mercuri E, Finkel RS, Foster R, Hughes SG, et al. An integrated safety analysis of infants and children with symptomatic spinal muscular atrophy (SMA) treated with Nusinersen in seven clinical trials. CNS Drugs. 2019;33:919\u201332.","journal-title":"CNS Drugs"},{"key":"1638_CR47","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.nmd.2018.05.010","volume":"28","author":"M Pane","year":"2018","unstructured":"Pane M, Palermo C, Messina S, Sansone VA, Bruno C, Catteruccia M, et al. Nusinersen in type 1 SMA infants, children and young adults: preliminary results on motor function. Neuromuscul Disord. 2018;28:582\u20135.","journal-title":"Neuromuscul Disord"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01638-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01638-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01638-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T13:15:24Z","timestamp":1674825324000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01638-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1638"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01638-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-50728\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-50728\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-50728\/v2","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"27 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Ethical Committee of Children\u2019s Hospital, Zhejiang University School of Medicine (2019-IRB-171). Informed consent was obtained from all <u>participants<\/u> before the study questionnaires were completed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent for publication has been obtained from all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}